Select a State ALL Non-USA AK AL AR AZ CA CO CT DC DE FL GA IA ID IL IN KS KY MA MD MI MN MO MS NC NE NH NJ NM NV NY OH OK OR PA PR RI SC TN TX UT VA WA WI WV WY Select a Protocol ALL ATS1 - Extended Follow Up of Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia ATS15 - Increasing Patching for Amblyopia Study ATS16 - Augmenting Atropine Treatment for Amblyopia Study ATS21 - Evaluation of Accommodative Behavior in Children With and Without Amblyopia ATS22 - A Randomized Trial to Evaluate Sequential vs Simultaneous Spectacles plus Patching C02 - Pediatric Cataract Surgery Outcomes Registry IXT1 - A Randomized Trial of Bilateral Lateral Rectus Recession versus Unilateral Recess-Resect for Intermittent Exotropia IXT1Ext - Extended Follow Up of a Randomized Trial of Bilateral Lateral Rectus Recession versus Unilateral Lateral Rectus Recession with Medial Rectus Resection for Intermittent Exotropia IXT5 - A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia IXT6 - A Pilot Randomized Clinical Trial of Base-in Prism Spectacles for Intermittent Exotropia ROP1 - Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity ROP2Y - Two-Year Follow Up after Treatment of Severe Retinopathy of Prematurity with Low-Dose Bevacizumab ROP3 - Compare low-dose bevacizumab (0.063 mg) vs laser for infants with type 1 ROP ROP4 - Evaluate doses of 0.063 mg and 0.25mg as treatment for type 1 ROP, with ROP and retinal vessels all in zone I No records are available.